Hey there! In this blog post, we're going to talk about ISOs, what they are, and why they matter in the Life Sciences sector. If you're in this industry, you've likely heard the term ISO thrown around, but do you know what it really means?
First things first, ISO stands for the International Organisation for Standardisation (don’t ask us why it’s not IOS). It's an independent NGO that develops and publishes international standards across a broad range of fields. In simple terms, ISOs are standards that an organisation can follow to ensure and prove that they meet specific requirements.
Two of the most well-known ISO standards are ISO 27001 and 9001. ISO 27001 is all about information security management. It outlines a framework for keeping sensitive company and customer information safe from unauthorised access and potential cyber threats. ISO 9001 focuses on quality management. It sets guidelines for organisations to consistently meet customer expectations and provide high-quality products and services.
So why do ISOs matter? In Life Sciences, ISO certifications are important for establishing trust between collaboration partners. They guarantee consistent quality management and robust information security practices for handling sensitive data, including patient information and intellectual property, and developing products and therapies directly impacting human health.
When a company is certified, it can demonstrate that it meets specific criteria and adheres to industry best practices. This builds confidence in the company's processes and ultimately accelerates long-term relationships built on trust.
But ISOs aren't just about external partnerships. Following these standards can also lead to good internal practice. By implementing ISOs, a company can create a culture of continuous improvement and ensure that they are constantly striving to meet the highest standards.
Of course, there are some downsides to ISOs as well. They can be challenging to obtain and maintain, especially for smaller companies with limited resources. It takes considerable time, effort, and money to complete the certification process and keep up with the standards over time.
In the world of data and trial management, it's essential to demonstrate to collaborators that we meet the criteria set out in ISO standards. We have got full ISO 27001 and 9001 certification and are delighted to have also been shortlisted as a finalist in The Chartered Quality Institute's International Quality Awards.
To summarise, ISOs are a set of standards that organisations can follow to ensure they are meeting specific requirements and criteria. ISO 27001 and 9001 are two of the most well-known standards focused on information security and quality management. While they can be challenging to obtain and maintain, ISO certification can be valuable for accelerating partnerships and good internal practice. Ultimately, it's essential to be ISO certified to build trust with our partners and ensure the safety and quality of data that form the basis of developing therapies impacting human health.
Lindus Health and Oto launch remote trial to combat tinnitus
We're excited to announce that we've launched a fully remote clinical study with Oto, a UK-based digital health startup, to combat tinnitus.
Announcing our $18m Series A led by investors Creandum and with participation from Peter Thiel
The funding comes from Spotify-backer Creandum, with participation from PayPal co-founder Peter Thiel and returning investors firstminute, Seedcamp, Hambro Perks, Amino Collective, Page One Ventures and Calm/Storm. Additional investment has been provided by angel investors including Nadav Rosenberg, Kaysan Nikkhah, Trevor Martin, Soraya Darabi, Andrej Steinberg, Tom Krüger and Mithi Thaya.
Why I joined Lindus Health - Anthony Brogno, Director of Clinical Operations
To break the mold of the CRO status quo. To leverage social medial and technology to support research operations. The Lindus Health culture. Hear more from Anthony Brogno, Director of Clinical Operations, on why he joined Lindus Health.
